Trial
NCT05289830
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
Escitalopram
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-10